Prime Medicine, Inc.

NASDAQ:PRME

Biotechnology

Healthcare
$3.82 -1.11%

-$0.04 today

Market cap
$694.94M
Beta
2.31
P/E (TTM)
-2.8
EPS (TTM)
-$1.12
52W Low $1.77High $6.94

Volume 4.62M

Average 2.47M

PRME Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Prime Medicine, Inc.NASDAQ: PRME

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares growth accelerates

Q1 FY2026 weighted avg shares of 177.1M shares rose 35.3% year over year, ahead of the +26.0% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 19.0% from the prior quarter. Over 3 fiscal years it compounded at +15.2% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +35.3% holds above the trailing-twelve-month pace of +26.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
177.1M+19.0% QoQ
Last fiscal yearDec 2025
148.76M+25.4% YoY
LTMMar 2026
153.89M+26.0% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+35.3%——
1 year+25.4%——
3-year CAGR+15.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
148.76M USD
Year-over-year change
+25.4%
4-year CAGR
+11.6%

Weighted Avg Shares vs competitors

How PRME compares with its peers on the latest reported figures

  • PRME's LTM Mar 2026 weighted avg shares of 153.89M shares is the highest of the 7 companies compared; the peer median is 94.49M shares.
  • Its year-over-year change of +26.0% is the highest of 7, against a peer median of +8.8%.
  • Over three fiscal years its annual growth of +15.2% compares with a peer median of +10.5%.
PRME Competitors Peer median
Weighted Avg Shares for PRME and competitors
Company Period LTM YoY 3-year CAGR
PRMEPrime Medicine, Inc.LTM Mar 2026153.89M +26.0%+15.2%
NTLAIntellia Therapeutics, Inc.LTM Mar 2026110.2M +9.3%+12.1%
BEAMBeam Therapeutics Inc.LTM Jun 2026103.26M +16.4%+12.2%
CRSPCRISPR Therapeutics AGLTM Sep 202694.81M +8.4%+5.0%
CRBUCaribou Biosciences, Inc.LTM Mar 202694.18M +3.6%+15.4%
EDITEditas Medicine, Inc.LTM Mar 202690.28M +9.3%+8.9%
DSGNDesign Therapeutics, Inc.LTM Mar 202658.14M +2.6%+1.0%
SCTXScribe Therapeutics Inc.—— ——
Peer median (excluding PRME) 94.49M+8.8%+10.5%

Competitors are the stored peer set for PRME. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0002.98M4.63M
Cost of Revenue00007.32M
Gross Profit0002.98M(2.69M)
Gross Margin———100.0%-58.1%
Research & Development70.55M86.73M147.91M155.29M160.64M
Selling, General & Admin13.92M29.82M43.39M50.16M52.35M
Operating Expenses84.47M116.54M204.79M205.45M205.66M
Depreciation & Amortization568K2.22M4.65M6.13M5.38M
EBITDA(165.29M)(120.55M)(186.64M)(189.75M)(195.76M)
EBITDA Margin———-6361.2%-4226.2%
Operating Income(84.47M)(116.54M)(204.79M)(202.47M)(208.35M)
Operating Margin———-6787.4%-4498.1%
Interest Income0003.52M4.15M
Interest Expense00000
Other Income / Expenses(81.38M)(6.23M)6.38M6.59M7.21M
Income Before Tax(165.85M)(122.77M)(198.41M)(195.88M)(201.14M)
Pre-Tax Margin———-6566.6%-4342.4%
Income Tax Expense(486K)(948K)(279K)00
Net Income(165.37M)(121.82M)(198.13M)(195.88M)(201.14M)
Net Margin———-6566.6%-4342.4%
EPS (Basic)(1.92)(1.46)(2.18)(1.65)(1.35)
EPS (Diluted)(1.92)(1.46)(2.18)(1.65)(1.35)
Weighted Avg Shares95.73M97.21M90.97M118.6M148.76M
Weighted Avg Shares (Diluted)95.73M97.21M90.97M118.6M148.76M

Prime Medicine, Inc.

NASDAQ:PRME

Intrinsic Alpha fair value

Locked

Current Price

$3.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.